Equity OfferingApr 6, 2026, 04:16 PM
Oncolytics Biotech Enters $75 Million Open Market Sale Agreement with Jefferies LLC
AI Summary
Oncolytics Biotech Inc. has entered into an Open Market Sale Agreement with Jefferies LLC, allowing the company to offer and sell up to $75 million of its common stock from time to time. This agreement provides Oncolytics with flexibility to raise capital, but may also dilute existing shareholders' equity.
Key Highlights
- Oncolytics Biotech can sell up to $75 million in common stock through Jefferies LLC.
- Sales will be conducted as an 'at the market offering' under Rule 415(a)(4).
- Jefferies will receive a commission of up to 3.0% of gross proceeds from each sale.
- The agreement can be terminated by either party with ten trading days' notice.